AI Science Tracker

UC San Diego Health

1 discovery from 2024

Discoveries

COMPOSER deep learning sepsis model linked to 17% lower in-hospital sepsis mortality

Across two UC San Diego Health emergency departments, 6,217 adult septic patients were studied before and after nurse-facing alerts driven by the COMPOSER model. Deployment was associated with a 1.9-point absolute (17% relative) drop in in-hospital sepsis mortality (95% CI 0.3-3.5%) and a 5-point rise in bundle compliance. The design is quasi-experimental, not randomized, and several authors co-founded a company that commercializes the tools.

Technology: COMPOSER (deep learning sepsis prediction model)

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: retrospective or benchmark
  • Tested: A quasi-experimental before-and-after comparison across two UC San Diego emergency departments (6,217 septic patients) measured in-hospital sepsis mortality and bundle compliance before and after COMPOSER-driven nurse alerts.
  • Still unknown: The design is quasi-experimental, not randomized; other limitations were not reported in the fetched abstract.
  • AI role: The COMPOSER deep-learning sepsis model triggered nurse-facing alerts.

Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1038/s41746-023-00986-6&resultType=core&format=json

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 207 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 5/5 · Validation 2/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.